86.94 USD
▼+8.91-0.42%
盘后 83.60 +0.18%
2026-07-31
市值
$32.81B
市盈率
34.28
EPS
2.54
股息率
—
52 周区间
54.11 – 87.00
成交量
6.12M
Beta
1.41
目标价
93.04
52W 低 54.1152W 高 87.00
价格走势
公司简介
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin;...